Showing results (81-90 of 263) with videos related to
Sort By:
Pageof 27
Progress in Clinical and Biological Research|January 1, 1991
Alpha lymphoblastoid interferon and acyclovir for chronic hepatitis deltaL Berk, R A de Man, C Housset, et al.Antiviral Research|May 1, 1989
beta 2-Microglobulin and antiviral therapy for chronic hepatitis type BR A de Man, J Lindemans, S W Schalm, et al.Nederlands Tijdschrift Voor Geneeskunde|March 22, 2007
[Changes in the management of patients with side effects from the treatment of hepatitis C]G Bezemer, S W Schalm, A R van Gool, et al.Metabolic Brain Disease|December 1, 1996
Diagnostic tools for the detection of subclinical hepatic encephalopathy: comparison of standard and computerized psychometric tests with spectral-EEGP Amodio, J C Quero, F Del Piccolo, et al.The British Journal of Radiology|April 1, 1993
Oesophageal varices: how reliable is a barium swallow?A Z Ginai, H R van Buuren, W C Hop, et al.Scandinavian Journal of Gastroenterology|June 1, 1984
T-lymphocyte subpopulations in patients with various courses after hepatitis B virus infectionJ van Hattum, A van Oudenaren, S W Schalm, et al.Tissue Antigens|January 1, 1977
HLA determinants in chronic active liver disease: possible relation of HLA-Dw3 to prognosisG Opelz, A J Vogten, W H Summerskill, et al.Vaccine|September 1, 1994
Anti-HBs levels in infants of hepatitis B carrier mothers after delayed active immunization with recombinant vaccine concomitant with DTP-polio vaccine: is there need for a second dose of HBIg? Dutch Study Group on Prevention of Neonatal Hepatitis BP M Grosheide, R del Canho, M Voogd, et al.Antiviral Research|July 1, 1987
Detection of HBV-DNA in liver biopsy and serum: its significance in the selection of hepatitis B patients for antiviral therapyR A Heijtink, P Smal, F J ten Kate, et al.Vaccine|May 1, 1994
Immunogenicity of standard and low dose vaccination using yeast-derived recombinant hepatitis B surface antigen in elderly volunteersS de Rave, R A Heijtink, M Bakker-Bendik, et al.Pageof 27